Your buddy likely hasn't read through all the DD... The 8Ks with the Advisor Board members, no toxic debt, products in clinical trials at the largest hospital in Israel that are having encouraging results, the distribution deals from guys that have so much faith they'll manufacture and market for a 10% royalty, and so on...
This isn't a Pink Sheet with toxic financing and broken promises.
It'll surpass AXIM and chase down GWPH in time. Maybe within this calendar year.